Katy E Trinkley1, Daniel C Malone2, Jennifer A Nelson3, Joseph J Saseen4. 1. Schools of Pharmacy and Medicine, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Mail Stop C238, Aurora, CO 80045, USA. 2. Department of Pharmacy Practice, University of Arizona, Tucson, AZ, USA. 3. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA. 4. Department of Family Medicine, University of Colorado, Aurora, CO, USA.
Abstract
BACKGROUND: The purpose of this study was to identify the reasons why metformin prescribing is suboptimal. METHODS: Two semi-structured focus groups with attitudinal questionnaires and a brief educational presentation were held in two US cities. Participants included providers (physicians, pharmacists, midlevel practitioners) caring for patients with type 2 diabetes mellitus (T2DM) in an ambulatory setting. Outcome measures included provider attitudes, behaviors and opinions regarding the use of metformin. RESULTS: Participants identified three main themes influencing the use of metformin, including the appropriate timing of metformin initiation, known risks associated with metformin, and procedures to manage safety concerns and mitigate adverse effects associated with metformin. Participant prescribing behaviors of metformin were not consistent with the best available evidence in the settings of renal insufficiency, heart failure, hepatic dysfunction, alcohol use, and lactic acidosis. With minimal education, provider prescribing behaviors appeared to change by the end of the focus group to align more closely with the best available evidence. CONCLUSIONS: Provider attitudes, behaviors and opinions regarding the use of metformin for T2DM reveals the need for further education to improve appropriate use of metformin. Educational interventions should target prescribing behaviors and opinions identified to be inconsistent with the evidence.
BACKGROUND: The purpose of this study was to identify the reasons why metformin prescribing is suboptimal. METHODS: Two semi-structured focus groups with attitudinal questionnaires and a brief educational presentation were held in two US cities. Participants included providers (physicians, pharmacists, midlevel practitioners) caring for patients with type 2 diabetes mellitus (T2DM) in an ambulatory setting. Outcome measures included provider attitudes, behaviors and opinions regarding the use of metformin. RESULTS:Participants identified three main themes influencing the use of metformin, including the appropriate timing of metformin initiation, known risks associated with metformin, and procedures to manage safety concerns and mitigate adverse effects associated with metformin. Participant prescribing behaviors of metformin were not consistent with the best available evidence in the settings of renal insufficiency, heart failure, hepatic dysfunction, alcohol use, and lactic acidosis. With minimal education, provider prescribing behaviors appeared to change by the end of the focus group to align more closely with the best available evidence. CONCLUSIONS: Provider attitudes, behaviors and opinions regarding the use of metformin for T2DM reveals the need for further education to improve appropriate use of metformin. Educational interventions should target prescribing behaviors and opinions identified to be inconsistent with the evidence.
Authors: Dean T Eurich; Sumit R Majumdar; Finlay A McAlister; Ross T Tsuyuki; Jeffrey A Johnson Journal: Diabetes Care Date: 2005-10 Impact factor: 19.112
Authors: Nihar R Desai; William H Shrank; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; Niteesh K Choudhry Journal: Am J Med Date: 2012-03 Impact factor: 4.965
Authors: Judith R Ricci; Charmaine Coulen; Jan E Berger; Marsha C Moore; Angela McQueen; Saira A Jan Journal: Am J Manag Care Date: 2009-11-01 Impact factor: 2.229
Authors: Dean T Eurich; Daniala L Weir; Sumit R Majumdar; Ross T Tsuyuki; Jeffrey A Johnson; Lisa Tjosvold; Saskia E Vanderloo; Finlay A McAlister Journal: Circ Heart Fail Date: 2013-03-18 Impact factor: 8.790
Authors: Shari Bolen; Leonard Feldman; Jason Vassy; Lisa Wilson; Hsin-Chieh Yeh; Spyridon Marinopoulos; Crystal Wiley; Elizabeth Selvin; Renee Wilson; Eric B Bass; Frederick L Brancati Journal: Ann Intern Med Date: 2007-07-16 Impact factor: 25.391
Authors: Sae Takada; Allison J Ober; Judith S Currier; Noah J Goldstein; Tamara B Horwich; Brian S Mittman; Suzanne B Shu; Chi-Hong Tseng; Tara Vijayan; Soma Wali; William E Cunningham; Joseph A Ladapo Journal: Prog Cardiovasc Dis Date: 2020-02-19 Impact factor: 8.194